Index Performance
Overview
Description
AI-driven diagnostics represents a transformative trend in the healthcare industry, leveraging artificial intelligence to enhance the accuracy and efficiency of medical diagnostics. This theme is driven by advancements in machine learning algorithms, increased availability of big data, and the integration of AI with medical imaging technologies. The growing demand for early and accurate disease detection, coupled with the need to reduce healthcare costs and improve patient outcomes, fuels the adoption of AI in diagnostics. Additionally, the regulatory support and significant investments from venture capital and established healthcare companies underscore the theme’s potential for substantial growth and innovation. - [[Machine Learning Algorithms for Diagnostics]]: AI algorithms that analyze patient data to predict and diagnose diseases. - [[AI-integrated Medical Imaging Technologies]]: Solutions that merge AI with imaging devices to improve the detection and analysis of medical images. - [[Predictive Analytics in Healthcare]]: Tools that use AI to predict health outcomes and provide risk assessments based on patient data. - [[Natural Language Processing (NLP) for Medical Records]]: AI systems that interpret and analyze medical records to support diagnostic decision-making. - [[AI-driven Pathology]]: Technologies that utilize AI to assist in the examination of tissue samples and identification of pathological conditions. This index was generated with help from Thematic Analyst.
- Inception Date06/05/2024
- WeightingEqual
- # of holdings24
What's inside?
Holdings
All holdings as of December 4, 2024
Lemonade, Inc. (LMND) | 9.57% | $3.22B | 15.13% | N/A | 3.05 |
Data Knights Acquisition Corp. (DKDCA) | 6.76% | N/A | N/A | -15.38% | 14.02 |
UiPath, Inc. (PATH) | 4.66% | $7.91B | 10.07% | 80.01% | 3.80 |
PagerDuty, Inc. (PD) | 4.53% | $1.91B | 9.41% | 82.96% | 3.47 |
RadNet, Inc. (RDNT) | 4.42% | $5.97B | 14.72% | 7.45% | 3.63 |
Synopsys, Inc. (SNPS) | 4.40% | $87.59B | 2.31% | 78.17% | 13.79 |
Zebra Technologies Corp. (ZBRA) | 4.26% | $20.96B | 30.67% | 46.62% | 4.48 |
Himax Technologies, Inc. (HIMX) | 4.25% | $950.37M | -5.86% | 29.95% | 0.89 |
Accelerate Diagnostics, Inc. (AXDX) | 4.16% | $39.32M | -9.82% | 28.77% | 6.77 |
iCAD, Inc. (ICAD) | 4.08% | $45.12M | 3.54% | 84.85% | 1.21 |
PDF Solutions, Inc. (PDFS) | 4.05% | $1.22B | 9.58% | 72.68% | 6.59 |
Quest Diagnostics, Inc. (DGX) | 3.99% | $18.07B | 8.41% | 31.51% | 2.50 |
indie Semiconductor, Inc. (INDI) | 3.98% | $813.72M | -10.77% | 39.35% | 3.65 |
Intel Corp. (INTC) | 3.81% | $96.91B | -6.17% | 15.03% | 2.47 |
Biotricity, Inc. (BTCY) | 3.70% | $7.02M | 12.99% | 75.28% | 2.41 |
QUALCOMM, Inc. (QCOM) | 3.68% | $180.63B | 8.77% | 56.21% | 4.99 |
Lantern Pharma, Inc. (LTRN) | 3.65% | $34.40M | N/A | N/A | N/A |
Analog Devices, Inc. (ADI) | 3.65% | $109.95B | -23.39% | 49.07% | 12.52 |
GE Healthcare Technologies, Inc. (GEHC) | 3.49% | $37.72B | 0.85% | 40.84% | 2.58 |
IDEXX Laboratories, Inc. (IDXX) | 3.26% | $35.38B | 6.56% | 61.05% | 11.09 |
IQVIA Holdings, Inc. (IQV) | 3.19% | $36.41B | 4.06% | 28.18% | 3.63 |
Diagnos, Inc. (ADK) | 3.01% | $20.28M | -30.68% | -1,276.96% | 206.16 |
Biodesix, Inc. (BDSX) | 2.85% | $197.84M | 34.54% | 76.98% | 4.44 |
Co-Diagnostics, Inc. (CODX) | 2.58% | $28.10M | -91.58% | -213.54% | 0.68 |